Enhancing antidepressant safety surveillance: comparative analysis of adverse drug reaction signals in spontaneous reporting and healthcare claims databases

被引:1
|
作者
Kim, Taehyung [1 ,2 ]
Jiang, Xinying [3 ,4 ]
Noh, Youran [1 ,2 ]
Kim, Maryanne [1 ,2 ]
Hong, Song Hee [1 ,2 ]
机构
[1] Seoul Natl Univ, Colleage Pharm, Seoul, South Korea
[2] Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul, South Korea
[3] Healthcare & Life Sci China, Shanghai, Peoples R China
[4] Renaissance Grp, Shanghai, Peoples R China
基金
新加坡国家研究基金会;
关键词
signal detection; drug safety surveillance; spontaneous reporting system; healthcare claim database; antidepressant; adverse drug reaction; pharmacovigilance; LARGE FREQUENCY TABLES; PERFORMANCE; SYSTEMS;
D O I
10.3389/fphar.2023.1291934
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background/Objective: Spontaneous reporting systems (SRS) such as the Korea Adverse Event Reporting System (KAERS) are limited in their ability to detect adverse drug reaction (ADR) signals due to their limited data on drug use. Conversely, the national health insurance claim (NHIC) data include drug use information for all qualifying residents. This study aimed to compare ADR signal profiles for antidepressants between KAERS and NHIC, evaluating the extent to which detected signals belong to common ADRs and labeling information.Materials and Methods: ADR signal detection in KAERS and NHIC databases, spanning January to December 2017, employed disproportionality analysis. Signal classes were determined based on System Organ Class (SOC) of the Medical Dictionary for Regulatory Activities (MedDRA). Also, Common ADR Coverage (CAC), the proportion of detected signals deemed common ADRs, and labeling information coverage (LIC) represented by mean average precision (mAP) were calculated. Additionally, protopathic bias and relative risk (RR) evaluation were performed to check for signal robustness.Results: Signal detection revealed 51 and 62 signals in KAERS and NHIC databases, respectively. Both systems predominantly captured signals related to nervous system disorders, comprising 33.3% (N = 17) in KAERS and 50.8% (N = 31) in NHIC. Regarding the type of antidepressants, KAERS predominantly reported signals associated with tricyclic antidepressants (TCAs) (N = 21, 41.2%), while NHIC produced most signals linked to selective serotonin reuptake inhibitors (SSRIs) (N = 22, 35.5%). KAERS exhibited higher CAC (68.63% vs. 29.03%) than NHIC. LIC was also higher in KAERS than in NHIC (mAP for EB05: 1.00 vs. 0.983); i.e., NHIC identified 5 signals not documented in drug labeling information, while KAERS found none. Among the unlabeled signals, one (Duloxetine-Myelopathy) was from protopathic bias, and two (duloxetine-myelopathy and tianeptine-osteomalacia) were statistically significant in RR.Conclusion: NHIC exhibited greater capability in detecting ADR signals associated with antidepressant use, encompassing unlabeled ADR signals, compared to KAERS. NHIC also demonstrated greater potential for identifying less common ADRs. Further investigation is needed for signals detected exclusively in NHIC but not covered by labeling information. This study underscores the value of integrating different sources of data, offering substantial regulatory insights and enriching the scope of pharmacovigilance.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system
    Jiao-Jiao Chen
    Xue-Chen Huo
    Shao-Xia Wang
    Fei Wang
    Quan Zhao
    International Journal of Clinical Pharmacy, 2022, 44 : 1351 - 1360
  • [42] Network Analysis for Signal Detection in Spontaneous Adverse Event Reporting Database: Application of Network Weighting Normalization to Characterize Cardiovascular Drug Safety
    Petervari, Matyas
    Benczik, Bettina
    Balogh, Oliver M.
    Petrovich, Balazs
    Agg, Bence
    Ferdinandy, Peter
    DRUG SAFETY, 2022, 45 (11) : 1423 - 1438
  • [43] Network Analysis for Signal Detection in Spontaneous Adverse Event Reporting Database: Application of Network Weighting Normalization to Characterize Cardiovascular Drug Safety
    Mátyás Pétervári
    Bettina Benczik
    Olivér M. Balogh
    Balázs Petrovich
    Bence Ágg
    Péter Ferdinandy
    Drug Safety, 2022, 45 : 1423 - 1438
  • [44] Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports
    Dubrall, Diana
    Schmid, Matthias
    Stingl, Julia Carolin
    Sachs, Bernhardt
    PLOS ONE, 2020, 15 (03):
  • [45] Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBaseA®
    Ampadu, Haggar H.
    Hoekman, Jarno
    de Bruin, Marieke L.
    Pal, Shanthi N.
    Olsson, Sten
    Sartori, Daniele
    Leufkens, Hubert G. M.
    Dodoo, Alexander N. O.
    DRUG SAFETY, 2016, 39 (04) : 335 - 345
  • [46] Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®
    Haggar H. Ampadu
    Jarno Hoekman
    Marieke L. de Bruin
    Shanthi N. Pal
    Sten Olsson
    Daniele Sartori
    Hubert G. M. Leufkens
    Alexander N. O. Dodoo
    Drug Safety, 2016, 39 : 335 - 345
  • [47] Comparative Safety Analysis of Serious Adverse Drug Events in North America: A 19-Year Study of FDA and Canadian Vigilance Databases
    Chalabianloo, Niaz
    Sedig, Kamran
    Muanda, Flory Tsobo
    DRUG SAFETY, 2024, 47 (12) : 1376 - 1377
  • [48] Exploring the utility of a spontaneous adverse drug reaction reporting system in identifying drug–drug interactions between antiretrovirals, antitubercular drugs, and cotrimoxazole: a case/non-case analysis
    Josiah Tatenda Masuka
    Anisa Mosam
    Star Khoza
    Drugs & Therapy Perspectives, 2020, 36 : 583 - 589
  • [49] Flupirtine-induced liver injury—Seven cases from the Berlin Case–control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database
    Antonios Douros
    Elisabeth Bronder
    Frank Andersohn
    Andreas Klimpel
    Michael Thomae
    Hans-Dieter Orzechowski
    Reinhold Kreutz
    Edeltraut Garbe
    European Journal of Clinical Pharmacology, 2014, 70 : 453 - 459
  • [50] Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial
    Kiguba, Ronald
    Mwebaza, Norah
    Ssenyonga, Ronald
    Ndagije, Helen Byomire
    Nambasa, Victoria
    Katureebe, Cordelia
    Katumba, Kenneth
    Tregunno, Phil
    Harrison, Kendal
    Karamagi, Charles
    Scott, Kathryn A.
    Pirmohamed, Munir
    BMJ OPEN, 2022, 12 (07):